<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
73704-010-00
</NDCCode>
<PackageDescription>
115 g in 1 BOTTLE, SPRAY (73704-010-00)
</PackageDescription>
<NDC11Code>
73704-0010-00
</NDC11Code>
<ProductNDC>
73704-010
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Ayrzinc
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Zinc Oxide, Dimethicone
</NonProprietaryName>
<DosageFormName>
SPRAY, SUSPENSION
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20200601
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part347
</ApplicationNumber>
<LabelerName>
Ayrton Saunders, INC
</LabelerName>
<SubstanceName>
DIMETHICONE; ZINC OXIDE
</SubstanceName>
<StrengthNumber>
10; 125
</StrengthNumber>
<StrengthUnit>
mg/g; mg/g
</StrengthUnit>
<Pharm_Classes>
Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Skin Barrier Activity [PE]
</Pharm_Classes>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2023-12-13
</LastUpdate>
<PackageNdcExcludeFlag>
N
</PackageNdcExcludeFlag>
<ProductNdcExcludeFlag>
N
</ProductNdcExcludeFlag>
<ListingRecordCertifiedThrough>
20231231
</ListingRecordCertifiedThrough>
<StartMarketingDatePackage>
20200601
</StartMarketingDatePackage>
<EndMarketingDatePackage/>
<SamplePackage>
N
</SamplePackage>
</NDC>